Stonebridge Capital Management Inc Bristol Myers Squibb CO Transaction History
Stonebridge Capital Management Inc
- $234 Million
- Q2 2024
A detailed history of Stonebridge Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stonebridge Capital Management Inc holds 22,590 shares of BMY stock, worth $970,918. This represents 0.4% of its overall portfolio holdings.
Number of Shares
22,590
Previous 22,590
-0.0%
Holding current value
$970,918
Previous $1.23 Million
23.43%
% of portfolio
0.4%
Previous 0.55%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,493Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.99 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.94 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.82 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.02 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $91.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...